Sensitizing tumors to anti-PD-1 therapy by promoting NK and CD8+ T cells via pharmacological activation of FOXO3

Young‐Min Chung(Gynecologic Oncology Group), Mickey C.‐T. Hu(Gynecologic Oncology Group)
Journal for ImmunoTherapy of Cancer
December 1, 2021
10.1136/jitc-2021-002772
Cited by 63

Related Papers

FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage
|Nature Communications|2012|102
Pharmacological activation of FOXO3 suppresses triple-negative breast cancer <i>in vitro</i> and <i>in vivo</i>
|Oncotarget|2016|54
Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation
|Scientific Reports|2014|48